山东威高骨科材料股份有限公司关于 补选公司第三届董事会非独立董事及聘任总经理的公告

Core Viewpoint - The company is undergoing a leadership change with the resignation of the former general manager and the appointment of a new non-independent director and general manager, Li Jinqiu, to ensure stable operations and governance [1][2][3]. Group 1: Board Restructuring - The former general manager, Lu Junqiang, resigned due to work adjustments, prompting the need for a new non-independent director and general manager [1]. - The board of directors approved the nomination of Li Jinqiu as a non-independent director candidate and his appointment as the general manager, pending shareholder approval [2][10]. Group 2: Upcoming Shareholder Meeting - The company plans to hold its third extraordinary general meeting on December 29, 2025, to discuss the board restructuring and other matters [12][15]. - The meeting will utilize both on-site and online voting methods, with specific timeframes for participation [16][19]. Group 3: Investment and Acquisition Strategy - The company intends to change part of its fundraising project to acquire a 55% stake in Suzhou Jiesibai Medical Technology Co., Ltd. for 86.46 million yuan, enhancing its competitive position in the orthopedic minimally invasive segment [40][46]. - This acquisition aligns with the company's strategic focus on expanding its product offerings in the orthopedic field, particularly in minimally invasive and energy-based devices [47][49].